| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/31/2009 | US7511038 Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors |
| 03/31/2009 | CA2448602C Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/26/2009 | WO2009039431A2 Substituted aryl-fused spirocyclic amines |
| 03/26/2009 | WO2009039135A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 03/26/2009 | WO2009039134A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | WO2009039127A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | WO2009038784A1 Triazole fused heteroaryl compounds as p38 kinase inhibitors |
| 03/26/2009 | WO2009037556A1 New agents for the treatment of the low urinary tract dysfunctions |
| 03/26/2009 | WO2009037302A1 5-substituted-1, 4-benz0diazepines as phosphodiesterase inhibitors |
| 03/26/2009 | WO2009037247A1 Pyrazine derivatives and their use as potassium channel modulators |
| 03/26/2009 | WO2009037244A2 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 03/26/2009 | WO2009037222A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | WO2009037172A1 Prodrugs to thyroid hormone analogs |
| 03/26/2009 | WO2009037155A1 Electroluminescent device |
| 03/26/2009 | WO2009036996A2 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | WO2009016460A3 Pyrazole compounds and their use as raf inhibitors |
| 03/26/2009 | WO2009007753A3 4- (3-aminopyrazole) -pyrimidine derivativee and their use as tyrosine kinase inhibitors for the treatment of cancer |
| 03/26/2009 | WO2009006389A8 Pyrimidine derivatives useful as raf kinase inhibitors |
| 03/26/2009 | WO2008141731A3 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 03/26/2009 | WO2008007211A8 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082404 Benzimidazoles |
| 03/26/2009 | US20090082396 5-aryl-4,5-dihydro-(1h)-pyrazolines as cannabinoid cb1 receptor agonists |
| 03/26/2009 | US20090082379 Novel Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082377 Matrix Metalloproteinase Inhibitors |
| 03/26/2009 | US20090082367 Triazole derivative or a salt thereof |
| 03/26/2009 | US20090082366 Hepatitis C treatment; deuterated telaprevir (VX-950) |
| 03/26/2009 | US20090082365 Trisubstituted Quinazolinone Derivatives as Vanilloid Antagonists |
| 03/26/2009 | US20090082363 Deuterium-enriched posaconazole |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082361 Deuterium-enriched imatinib |
| 03/26/2009 | US20090082330 Certain substituted amides, method of making, and method of use thereof |
| 03/26/2009 | US20090082329 Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082310 Prodrugs of thyroid hormone analogs |
| 03/26/2009 | US20090081165 Bicyclic heteroaryl derivatives |
| 03/26/2009 | US20090079343 Organic electroluminescent device |
| 03/26/2009 | CA2700051A1 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | CA2699989A1 N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor |
| 03/26/2009 | CA2699986A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | CA2699981A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | CA2699338A1 Prodrugs to thyroid hormone analogs |
| 03/26/2009 | CA2698527A1 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 03/26/2009 | CA2696508A1 Diacylglycerol acyltransferase inhibitors |
| 03/25/2009 | EP2039693A2 Novel synthesis of irbesartan |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/25/2009 | EP2039683A2 Vasculostatic agents and methods of use thereof |
| 03/25/2009 | EP2038275A2 Novel pyridazine compound and use thereof |
| 03/25/2009 | EP2038274A2 Transcription factor modulating compounds and methods of use thereof |
| 03/25/2009 | EP2038273A1 A process for preparing 5-bromo-3-[(r)-1-methyl-pyrrolidin-2-ylmethyl]-1h-indole |
| 03/25/2009 | EP2038264A1 Tetrazole-substituted arylamides |
| 03/25/2009 | EP2038263A1 Novel aromatic aza heterocycles, method of production and use of the material in organic electronics |
| 03/25/2009 | EP2038262A2 Triazole compounds that modulate hsp90 activity |
| 03/25/2009 | EP2038261A2 Pyrazine derivatives with extended conjugation and uses thereof |
| 03/25/2009 | EP2038259A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same |
| 03/25/2009 | EP2038254A2 Bicyclic compositions and methods for modulating a kinase cascade |
| 03/25/2009 | EP2038146A2 Gas generant compositions |
| 03/25/2009 | EP2037741A1 Compositions and methods relating to novel compounds and targets thereof |
| 03/25/2009 | EP1991514A4 Novel anthracene derivative and organic electronic device using the same |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1718624B1 Benzamide derivatives and their use as glucokinase activating agents |
| 03/25/2009 | EP1696931B1 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 03/25/2009 | EP1353692B1 Methods and compositions for treatment of ocular neovascularization and neural injury |
| 03/25/2009 | CN101395157A Pyrrazole derivatives as sigma receptors antagonists |
| 03/25/2009 | CN101395148A N-formyl hydroxylamine compounds |
| 03/25/2009 | CN100471858C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 03/25/2009 | CN100471854C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/24/2009 | US7507836 Benzamide modulators of metabotropic glutamate receptors |
| 03/24/2009 | US7507756 (2-Chlorophenyl)-[2-(1-isopropyl-piperidin-4-ylmethoxy)-3-methyl-3H-imidazol-4-yl]-]-methanone; histamine receptor antagonist; neurologic disorders; reacting imidazole compound with base and perhaloalkane, to form 2-haloimidazole, and with electrophile to form C-5 position substituted imidazole compound |
| 03/24/2009 | US7507755 Inhibitors of cathepsin s |
| 03/24/2009 | US7507734 Pyridazinone derivatives |
| 03/24/2009 | US7507732 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds; 5-HT2c receptor agonists; to treat diseases like obesity, depression, atypical depression, anxiety, epilepsy, lower urinary tract dysfunction; less toxic; selectivity |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2224060C Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/19/2009 | WO2009036144A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists |
| 03/19/2009 | WO2009036117A1 Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists |
| 03/19/2009 | WO2009035543A1 Dual-acting antihypertensive agents |
| 03/19/2009 | WO2009035296A2 Organic compound, and organic photoelectric device including the same |
| 03/19/2009 | WO2009035295A2 Organic compound, and organic photoelectric device including the same |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009034388A1 Compounds for the treatment of metabolic disorders |
| 03/19/2009 | WO2009034326A1 Phthalazinone derivatives |
| 03/19/2009 | WO2009034062A1 Compounds which inhibit the glycine transporter and uses thereof in medicine |
| 03/19/2009 | WO2009034061A1 Spiro-condensed imidazolone derivatives inhibiting the glycine transporter |
| 03/19/2009 | WO2009007536A3 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 03/19/2009 | WO2009007390A3 2-pyraz inylbenz imidazole derivatives as receptor tyrosine kinase inhibitors |
| 03/19/2009 | WO2009006567A3 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/19/2009 | WO2009005646A3 Substituted piperazines as cb1 antagonists |
| 03/19/2009 | WO2008153793A3 Gamma secretase modulators |
| 03/19/2009 | WO2008149379A3 Novel compounds |
| 03/19/2009 | WO2008005511A8 Novel inhibitors of hepatitis c virus replication |
| 03/19/2009 | US20090076276 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors |
| 03/19/2009 | US20090076273 such as 2-(4-{4-[N'-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidino]-butyl}phenoxy)-N-(3-dimethylaminopropyl)acetamide dimethanesulfonate, having prolonged pharmacodynamic half-life on mucosal surfaces, used for the treatment of cardiovascular disorders |
| 03/19/2009 | US20090076120 Crystal of Aminopyrrolidine Derivative and Production Method Thereof |
| 03/19/2009 | US20090076107 Deuterium-enriched odansetron |
| 03/19/2009 | US20090076104 Deuterium-enriched losartan |
| 03/19/2009 | US20090076047 2-Substituted Hydroxylaminopyrimidine, Method for the Production and the Use Thereof in the Form of Pesticides |
| 03/19/2009 | US20090076028 Deuterium-enriched itraconazole |
| 03/19/2009 | US20090076022 Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety |